Representatives of various employers in the pharmaceutical industry spoke about the priority challenges to maximize the position that the sector has acquired after the pandemic. BioSim participated in the Farmaforum round table that brought together four business associations, highlighting the need to achieve attractive conditions for the commercialization of new biosimilars and promote their use as keys to a more sustainable future with greater access to biological drugs. .